PMA device
Paradigm Real-Time Revel System
Medtronic Minimed · Sensor, Glucose, Invasive (MDS, Class III) · First FDA decision Oct 13, 2010, newest Dec 7, 2015Diabetes
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
0
Naming "Paradigm Real-Time Revel"
MAUDE reports
194,181
Brand "Paradigm Real-Time Revel", since 2015
PubMed studies
0
Mentioning "Paradigm Real-Time Revel"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 2 of 2 decisions filed under this name.
P150019 · Decided Dec 7, 2015 · 180 days after receipt
Device type: Sensor, glucose, invasive (MDS) · Laboratory Medicine & Pathology
- PARADIGM REAL-TIME REVEL INSULIN PUMPPMA supplement
P980022-S089 · Decided Oct 13, 2010 · 9 days after receipt · Normal 180 Day Track No User Fee
Device type: Sensor, glucose, invasive (MDS) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Paradigm Real-Time Revel", any status and sponsor, newest update first.
No registered device study names "Paradigm Real-Time Revel".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Paradigm Real-Time Revel", and for the whole product code for context.
This brand
194,181 reports: 124,140 malfunction, 68,928 injury, 1,091 death
Whole product code MDS
232,139 reports: 226,671 malfunction, 5,201 injury, 215 death
Newest reports for this brand
Medtronic Puerto Rico Operations Co.
2032227-2026-261546 · Received Oct 26, 2026 · Event dated Oct 11, 2026
Device type: Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (OYC)
Device problem as coded: Detachment of Device or Device Component
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
Medtronic Puerto Rico Operations Co.
2032227-2026-256732 · Received Oct 16, 2026 · Event dated Sep 2, 2025
Device type: Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (OYC)
Device problem as coded: Power Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
Medtronic Puerto Rico Operations Co.
2032227-2026-256784 · Received Oct 16, 2026 · Event dated Mar 16, 2025
Device type: Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (OYC)
Device problem as coded: Mechanical Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
Medtronic Puerto Rico Operations Co.
2032227-2026-252124 · Received Oct 8, 2026 · Event dated Sep 24, 2026
Device type: Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (OYC)
Device problem as coded: Battery Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
Medtronic Puerto Rico Operations Co.
2032227-2026-251283 · Received Oct 7, 2026 · Event dated Sep 19, 2026
Device type: Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (OYC)
Device problem as coded: Obstruction of Flow
Patient problem as coded: Hypoglycemia
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Paradigm REAL-Time Insulin Pump (MMT-522, MMT-722)Open, Classified
Z-1749-2026 · Started Feb 13, 2026 · Posted by FDA Apr 2, 2026
Reason given: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and...
Cause as FDA categorized it: Device Design · Device type: Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (OYC)
- Paradigm REAL-Time Revel Insulin Pump (MMT-523, MMT-723)Open, Classified
Z-1750-2026 · Started Feb 13, 2026 · Posted by FDA Apr 2, 2026
Reason given: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and...
Cause as FDA categorized it: Device Design · Device type: Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (OYC)
Z-1256-2025 · Started Jan 31, 2025 · Posted by FDA Mar 3, 2025
Reason given: All Medtronic MiniMed pumps (Paradigm series, Minimed 530G, 6XX series, and 7XX series) were found to have the potential for abnormal insulin delivery due to changes in air pressure, which can be found during airplane take-off or landing. An unexpected additional dose of insulin, which can occur during take-off, can...
Cause as FDA categorized it: Device Design · Device type: Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (OYC)
- Medtronic MiniMed Paradigm Insulin pump, model number MMT-522Open, Classified
Z-1587-2020 · Started Jun 27, 2019 · Posted by FDA Mar 26, 2020
Reason given: The action is being initiated due to potential cybersecurity vulnerabilities related to a series of insulin pumps that are designed to communicate using a wireless radio frequency (RF). An unauthorized person could potentially connect wirelessly to a nearby insulin pump to change settings and control insulin delivery.
Cause as FDA categorized it: Device Design · Device type: Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (OYC)
- Medtronic MiniMed Paradigm Insulin pump, model number MMT-722Open, Classified
Z-1588-2020 · Started Jun 27, 2019 · Posted by FDA Mar 26, 2020
Reason given: The action is being initiated due to potential cybersecurity vulnerabilities related to a series of insulin pumps that are designed to communicate using a wireless radio frequency (RF). An unauthorized person could potentially connect wirelessly to a nearby insulin pump to change settings and control insulin delivery.
Cause as FDA categorized it: Device Design · Device type: Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (OYC)
- Medtronic MiniMed Paradigm Insulin pump, model number MMT-522KOpen, Classified
Z-1589-2020 · Started Jun 27, 2019 · Posted by FDA Mar 26, 2020
Reason given: The action is being initiated due to potential cybersecurity vulnerabilities related to a series of insulin pumps that are designed to communicate using a wireless radio frequency (RF). An unauthorized person could potentially connect wirelessly to a nearby insulin pump to change settings and control insulin delivery.
Cause as FDA categorized it: Device Design · Device type: Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (OYC)
- Medtronic MiniMed Paradigm Insulin pump, model number MMT-722KOpen, Classified
Z-1590-2020 · Started Jun 27, 2019 · Posted by FDA Mar 26, 2020
Reason given: The action is being initiated due to potential cybersecurity vulnerabilities related to a series of insulin pumps that are designed to communicate using a wireless radio frequency (RF). An unauthorized person could potentially connect wirelessly to a nearby insulin pump to change settings and control insulin delivery.
Cause as FDA categorized it: Device Design · Device type: Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (OYC)
- Medtronic MiniMed Paradigm Insulin pump, model number MMT-523Open, Classified
Z-1591-2020 · Started Jun 27, 2019 · Posted by FDA Mar 26, 2020
Reason given: The action is being initiated due to potential cybersecurity vulnerabilities related to a series of insulin pumps that are designed to communicate using a wireless radio frequency (RF). An unauthorized person could potentially connect wirelessly to a nearby insulin pump to change settings and control insulin delivery.
Cause as FDA categorized it: Device Design · Device type: Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (OYC)
- Medtronic MiniMed Paradigm Insulin pump, model number MMT-523KOpen, Classified
Z-1592-2020 · Started Jun 27, 2019 · Posted by FDA Mar 26, 2020
Reason given: The action is being initiated due to potential cybersecurity vulnerabilities related to a series of insulin pumps that are designed to communicate using a wireless radio frequency (RF). An unauthorized person could potentially connect wirelessly to a nearby insulin pump to change settings and control insulin delivery.
Cause as FDA categorized it: Device Design · Device type: Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (OYC)
- Medtronic MiniMed Paradigm Insulin pump, model number MMT-723KOpen, Classified
Z-1593-2020 · Started Jun 27, 2019 · Posted by FDA Mar 26, 2020
Reason given: The action is being initiated due to potential cybersecurity vulnerabilities related to a series of insulin pumps that are designed to communicate using a wireless radio frequency (RF). An unauthorized person could potentially connect wirelessly to a nearby insulin pump to change settings and control insulin delivery.
Cause as FDA categorized it: Device Design · Device type: Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (OYC)
Showing the 10 newest of 14 recall records in FDA's data.
Published research
The most relevant PubMed records for "Paradigm Real-Time Revel"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code MDS.
- Dexcom G4 Platinum Continuous Glucose Monitoring System and Dexcom 5 Mobile Continuous Glucose Monitoring SystemDexcom, Inc. · PMA 2018
- G5 Mobile Continuous Glucose Monitoring SystemDexcom, Inc. · PMA 2024
- FreeStyle Libre Pro Flash Glucose Monitoring SystemAbbott Diabetes Care, Inc. · PMA 2020
- Freestyle Navigator Continuous Glucose Monitoring SystemAbbott Laboratories · PMA 2011
- Paradigm Real-Time Insulin PumpMedtronic Minimed · PMA 2015
- Medtronic Minimed Continuous Glucose Monitoring SystemMedtronic Minimed · PMA 2011
- Guardian Connect SystemMedtronic Minimed · PMA 2025
- Dexcom Seven SystemDexcom, Inc. · PMA 2009
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.